High degree of remission in pediatric severe asthma patients treated with biologics in a real-world setting. [PDF]
Cerda Reyes S +2 more
europepmc +1 more source
Fractional exhaled nitric oxide and blood eosinophils in relation to lung function, allergy and nasal polyps in asthma. [PDF]
Abohalaka R +10 more
europepmc +1 more source
Response to benralizumab in patients with severe eosinophilic asthma. [PDF]
Velasco-Santos JI +3 more
europepmc +1 more source
Development and internal validation of a multidimensional nomogram integrating PIV, LDH, and FeNO for predicting poor asthma control in school-aged children. [PDF]
Zhan Z, Xu T, Huang S.
europepmc +1 more source
Breathing Out the Truth: What Fractional Exhaled Nitric Oxide Really Tells Us About Pediatric Asthma. [PDF]
Mihai A +8 more
europepmc +1 more source
Fractional Exhaled Nitric Oxide in Children with Non-Cystic Fibrosis Bronchiectasis: Associations with Etiology, Lung Function, and CT Extent. [PDF]
Adiguzel T, Karadag B.
europepmc +1 more source
Serum and Nasal Lavage Fluid Eosinophil-Derived Neurotoxin Levels in Clinically Defined Asthma Phenotypes. [PDF]
Özuygur Ermis SS +15 more
europepmc +1 more source
Development and Internal Evaluation of a Clinical-Physiological Model for Predicting Methacholine-Defined Airway Hyperresponsiveness in Children Aged 0-3 Years. [PDF]
Qin J +5 more
europepmc +1 more source
Biologic Therapies and Biomarkers in Severe Childhood Asthma: A Systematic Review of Omalizumab and Mepolizumab. [PDF]
Gusmão ABF +7 more
europepmc +1 more source
Biological treatments for asthma and chronic obstructive pulmonary disease. [PDF]
Tejwani V +4 more
europepmc +1 more source

